title: [Research in developing countries: will leprosy vaccine be produced in Nepal?].
abstract: Clinical, bacteriological and immunological research into leprosy is pursued at the Anandaban Leprosy Hospital on the outskirts of Kathmandu in Nepal with support from the World Health Organization and research laboratories in inter alia Holland and Australia. The bacteriological part consists of research into cultivation procedures on mice for diagnosis of Mycobacterium Leprae resistance to dapsone and rifampicin. Serological studies have also yielded M. Leprae-specific antibodies, a method which, it is hoped, will be further developed as an aid to diagnosis and follow-up of treatment. Research concerning a leprosy vaccine is also in progress.
authors: G
authors: G
authors: Kurlberg
mesh_terms: D001428:Bacterial Vaccines / Q000302:isolation & purification*; D006801:Humans; D007917:Leprostatic Agents / Q000494:pharmacology; D007918:Leprosy / Q000517:prevention & control*; D009166:Mycobacterium leprae / Q000187:drug effects / Q000276:immunology*; D012106:Research; D014944:World Health Organization
chemical_list: D001428:Bacterial Vaccines; D007917:Leprostatic Agents; C060596:anti-leprosy vaccine
vernacular_title: Forskning i u-land: kommer lepravaccinet att framställas i Nepal?